Learn More
Biomatik Corporation Recombinant Human Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)
Supplier: Biomatik Corporation RPU41086
Recombinant Human Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) is a purified Prokaryotic Protein. Purity: >95% by SDS-PAGE. Host: E. coli. Endotoxin Level: <1.0EU per 1ug, by the LAL method. Species: Human (Homo sapiens). Target Name: Cyclin Dependent Kinase Inhibitor 2A (CDKN2A). Target Synonyms: P16; ARF; CDK4I; CMM2; INK4; INK4a; MLM; MTS1; TP16; P14; P14ARF; P16INK4a; P19; Melanoma P16; Cyclin-dependent kinase 4 inhibitor A; Multiple tumor suppressor 1. Accession Number: P42771. Gene ID: 1029. Expression Region: Ser8~Asp156. Tag Info: N-terminal His Tag. Theoretical MW: 20kDa. Buffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose. Storage: -20°C. Avoid repeated freeze/thaw cycles. Restrictions: For Research Use Only. Not for use in diagnostic procedures.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.